Key variables examined in gestational diabetes advance

March 18, 2013
Key variables examined in gestational diabetes advance
For women with gestational diabetes mellitus, clinical and genetic factors including higher pre-pregnancy body mass index are associated with development of type 2 diabetes mellitus, according to a study published online March 7 in the Journal of Clinical Endocrinology.

(HealthDay)—For women with gestational diabetes mellitus (GDM), clinical and genetic factors including higher pre-pregnancy body mass index are associated with development of type 2 diabetes mellitus (T2DM), according to a study published online March 7 in the Journal of Clinical Endocrinology.

Soo Heon Kwak, M.D., from the Seoul National University Hospital in Korea, and colleagues conducted a hospital-based that enrolled 843 women with GDM to examine the clinical and that are associated with the development of early or late T2DM.

The researchers found that 12.5 percent of subjects had T2DM at two months postpartum (early converters). Late converters included a further 23.8 percent of the remaining 370 subjects who developed T2DM during more than one year of follow-up. Higher pre-pregnancy body mass index, higher area under the curve of glucose during an antepartum , lower fasting insulin concentration, and decreased beta-cell function were independent risk factors for early converters. Higher pre-pregnancy and higher glucose area under the curve were independent risk factors for late converters. Early conversion was associated with variants in CDKN2A/2B and HHEX, while late conversion correlated with variants in CDKAL1.

"In conclusion, a significant portion of GDM subjects progress to T2DM in the early postpartum period and continue to have a high incidence of T2DM at later periods," the authors write. "This strongly supports the current recommendation that GDM women be tested for their glucose tolerance status at two months postpartum and annually thereafter."

Explore further: Low adiponectin in first trimester linked to GDM

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Low adiponectin in first trimester linked to GDM

February 1, 2013
(HealthDay)—Low adiponectin levels during the first trimester of pregnancy correlate with a higher level of insulin resistance and an increased risk of developing gestational diabetes mellitus (GDM), according to research ...

Gestational diabetes, obesity impact pregnancy outcomes

March 2, 2012
(HealthDay) -- Women with gestational diabetes mellitus (GDM) who are obese have significantly higher odds of adverse pregnancy outcomes, according to findings from the multinational Hyperglycemia and Adverse Pregnancy Outcome ...

Hemoglobin A1C inadequate for postpartum diabetes screening

June 19, 2012
(HealthDay) -- For postpartum women who have had gestational diabetes mellitus (GDM), the hemoglobin A1c (A1C) test criteria alone or in combination with fasting glucose test criteria does not provide sensitive and specific ...

Hip circumference inversely tied to diabetes risk

September 18, 2012
(HealthDay)—There is an inverse relationship between hip circumference and risk of type 2 diabetes mellitus (T2DM), according to a meta-analysis published online Sept. 3 in Obesity Reviews.

U-shaped link for BMI at diagnosis with mortality in T2DM

November 16, 2012
(HealthDay)—For patients with type 2 diabetes mellitus (T2DM), classification as normal weight or obese within a year of initial diabetes diagnosis correlates with significantly higher mortality, forming a U-shaped association ...

Absolute incretin effect reduced in type 2 diabetes

June 25, 2012
(HealthDay) -- For patients with type 2 diabetes mellitus (T2DM) the absolute incretin effect is reduced compared with healthy individuals, but its relative importance is increased, particularly in first-phase insulin secretion, ...

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.